vs

Side-by-side financial comparison of Carter Bankshares, Inc. (CARE) and Canopy Growth Corp (CGC). Click either name above to swap in a different company.

Canopy Growth Corp is the larger business by last-quarter revenue ($54.4M vs $39.8M, roughly 1.4× Carter Bankshares, Inc.). On growth, Carter Bankshares, Inc. posted the faster year-over-year revenue change (15.4% vs -0.3%). Over the past eight quarters, Carter Bankshares, Inc.'s revenue compounded faster (9.1% CAGR vs 1.2%).

Carter Bankshares, Inc. is a U.S. regional bank holding company operating Carter Bank & Trust, a community-focused financial institution. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, and wealth management services, primarily serving consumers and small business clients across Virginia and North Carolina.

Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a cannabis company based in Smiths Falls, Ontario.

CARE vs CGC — Head-to-Head

Bigger by revenue
CGC
CGC
1.4× larger
CGC
$54.4M
$39.8M
CARE
Growing faster (revenue YoY)
CARE
CARE
+15.7% gap
CARE
15.4%
-0.3%
CGC
Faster 2-yr revenue CAGR
CARE
CARE
Annualised
CARE
9.1%
1.2%
CGC

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CARE
CARE
CGC
CGC
Revenue
$39.8M
$54.4M
Net Profit
$-45.7M
Gross Margin
28.8%
Operating Margin
27.8%
-35.3%
Net Margin
-84.0%
Revenue YoY
15.4%
-0.3%
Net Profit YoY
48.6%
EPS (diluted)
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CARE
CARE
CGC
CGC
Q4 25
$39.8M
$54.4M
Q3 25
$39.1M
$48.7M
Q2 25
$37.3M
$52.7M
Q1 25
$37.0M
$47.5M
Q4 24
$34.5M
$54.6M
Q3 24
$34.2M
$46.0M
Q2 24
$33.6M
$48.3M
Q1 24
$33.5M
$53.1M
Net Profit
CARE
CARE
CGC
CGC
Q4 25
$-45.7M
Q3 25
$5.4M
$-1.2M
Q2 25
$8.5M
$-30.3M
Q1 25
$9.0M
Q4 24
$-89.0M
Q3 24
$5.6M
$-93.7M
Q2 24
$4.8M
$-92.8M
Q1 24
$5.8M
Gross Margin
CARE
CARE
CGC
CGC
Q4 25
28.8%
Q3 25
32.8%
Q2 25
25.0%
Q1 25
16.2%
Q4 24
32.2%
Q3 24
34.7%
Q2 24
34.8%
Q1 24
21.3%
Operating Margin
CARE
CARE
CGC
CGC
Q4 25
27.8%
-35.3%
Q3 25
18.3%
-25.3%
Q2 25
28.5%
-31.4%
Q1 25
30.1%
Q4 24
31.0%
-31.9%
Q3 24
20.5%
-72.9%
Q2 24
17.6%
-44.0%
Q1 24
21.6%
Net Margin
CARE
CARE
CGC
CGC
Q4 25
-84.0%
Q3 25
13.9%
-2.5%
Q2 25
22.8%
-57.6%
Q1 25
24.2%
Q4 24
-163.0%
Q3 24
16.4%
-203.7%
Q2 24
14.3%
-192.0%
Q1 24
17.4%
EPS (diluted)
CARE
CARE
CGC
CGC
Q4 25
$0.38
Q3 25
$0.24
Q2 25
$0.37
Q1 25
$0.39
Q4 24
$0.36
Q3 24
$0.24
Q2 24
$0.21
Q1 24
$0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CARE
CARE
CGC
CGC
Cash + ST InvestmentsLiquidity on hand
$271.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$419.7M
$553.5M
Total Assets
$4.9B
$807.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CARE
CARE
CGC
CGC
Q4 25
$271.1M
Q3 25
$217.6M
Q2 25
$104.8M
Q1 25
$96.0M
Q4 24
$130.2M
Q3 24
$168.8M
Q2 24
$142.3M
Q1 24
$148.5M
Stockholders' Equity
CARE
CARE
CGC
CGC
Q4 25
$419.7M
$553.5M
Q3 25
$412.8M
$537.3M
Q2 25
$405.6M
$357.0M
Q1 25
$401.8M
$355.7M
Q4 24
$384.3M
$431.8M
Q3 24
$386.8M
$372.1M
Q2 24
$364.4M
$389.0M
Q1 24
$359.1M
$365.3M
Total Assets
CARE
CARE
CGC
CGC
Q4 25
$4.9B
$807.5M
Q3 25
$4.8B
$781.0M
Q2 25
$4.8B
$660.4M
Q1 25
$4.7B
$669.9M
Q4 24
$4.7B
$849.9M
Q3 24
$4.6B
$899.6M
Q2 24
$4.5B
$938.9M
Q1 24
$4.6B
$949.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CARE
CARE
CGC
CGC
Operating Cash FlowLast quarter
$39.9M
Free Cash FlowOCF − Capex
$31.8M
FCF MarginFCF / Revenue
79.9%
Capex IntensityCapex / Revenue
20.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$54.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CARE
CARE
CGC
CGC
Q4 25
$39.9M
Q3 25
$11.8M
Q2 25
$9.6M
$-7.5M
Q1 25
$6.4M
$-121.0M
Q4 24
$36.9M
Q3 24
$10.3M
Q2 24
$-2.5M
$-37.8M
Q1 24
$17.6M
$-205.8M
Free Cash Flow
CARE
CARE
CGC
CGC
Q4 25
$31.8M
Q3 25
$10.3M
Q2 25
$7.7M
$-8.5M
Q1 25
$4.9M
$-128.9M
Q4 24
$28.8M
Q3 24
$8.4M
Q2 24
$-4.3M
$-40.7M
Q1 24
$16.3M
$-208.3M
FCF Margin
CARE
CARE
CGC
CGC
Q4 25
79.9%
Q3 25
26.3%
Q2 25
20.6%
-16.1%
Q1 25
13.1%
-271.5%
Q4 24
83.5%
Q3 24
24.6%
Q2 24
-12.7%
-84.1%
Q1 24
48.8%
-392.1%
Capex Intensity
CARE
CARE
CGC
CGC
Q4 25
20.2%
Q3 25
3.9%
Q2 25
5.1%
1.8%
Q1 25
4.1%
16.6%
Q4 24
23.6%
Q3 24
5.5%
Q2 24
5.4%
5.9%
Q1 24
3.9%
4.7%
Cash Conversion
CARE
CARE
CGC
CGC
Q4 25
Q3 25
2.18×
Q2 25
1.13×
Q1 25
0.71×
Q4 24
Q3 24
1.83×
Q2 24
-0.51×
Q1 24
3.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CARE
CARE

Segment breakdown not available.

CGC
CGC

Other$24.0M44%
Canadian Adult Use Cannabis$22.9M42%
International Markets Cannabis$6.2M11%
Other Geographical Area$1.2M2%

Related Comparisons